Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of ...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ...

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm ...

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, welcomes U.S.